glp 1 agonist drug interactions GLP-1 Receptor Agonists Frontiers | GLP−1 receptor agonists
Description
Phosphoglycerate mutase 5 initiates inflammation in acute kidney injury by triggering mitochondrial DNA release by dephosphorylating the pro-apoptotic protein Bax
Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B, et al
This is why GLP-1 is used as an active ingredient in GLP-1 program to help control appetite, ultimately leading to weight loss
RAAS inhibitors remain foundational, especially for albuminuric CKD, while GLP-1RAs offer modest albuminuria reduction and strong cardiovascular benefit, but less direct renal protection compared to SGLT2is [123]
10.1016/j.tips.2009.08.003 195 YoshidaT.AkahoshiF.SakashitaH.KitajimaH.NakamuraM.SondaS.et al (2012)
